-

Owens & Minor Announces Major Innovations to Products & Healthcare Services Network

Transformative investments in technology, automation and analytics capabilities will help improve supply chain visibility and resiliency for Products & Healthcare Services customers and lay the foundation for future innovations

RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor, Inc. (NYSE: OMI) today announced important milestones in advancing the medical distribution capabilities of its Products & Healthcare Services (P&HS) business segment, which provides essential products and services to thousands of healthcare customers. These milestones are the result of recent company investments in new technology, automation and analytics capabilities geared specifically toward driving greater efficiencies for the P&HS segment and improving the customer experience. Initial roll out will focus on two new Owens & Minor distribution centers in West Virginia and South Dakota.

Transformative investments in technology, automation and analytics capabilities will help improve supply chain visibility and resiliency for Products & Healthcare Services customers

Share

“Over the past two years, our P&HS teammates have worked creatively and diligently to identify areas where technology investments, operational upgrades and new approaches to how we do business could have a meaningful impact for our customers,” said Andy Long, EVP and CEO, Products & Healthcare Services, Owens & Minor. “We’re excited for these advancements to go live in West Virginia and South Dakota and look forward to the benefits they will provide for other Owens & Minor customers in years to come.”

These new capabilities will be operational at two new Owens & Minor sites starting in 2025:

  • A new state of the art distribution center with advanced automation and robotics technology to help streamline and expedite inventory management and order fulfilment in West Virginia (now open)
  • A second state of the art distribution center in South Dakota that will integrate the latest augmented reality (AR) system for supporting the order picking process (opening spring 2025)

About Owens & Minor

Owens & Minor, Inc. (NYSE: OMI) is a Fortune 500 global healthcare solutions company providing essential products and services that support care from the hospital to the home.

For over 100 years, Owens & Minor and its affiliated brands, Apria®, Byram®, and HALYARD*, have helped to make each day better for the patients, providers, and communities we serve. Powered by more than 20,000 teammates worldwide, Owens & Minor delivers comfort and confidence behind the scenes so healthcare stays at the forefront. Owens & Minor exists because every day, everywhere, Life Takes Care™.

For more information about Owens & Minor and our affiliated brands, visit owens-minor.com or follow us on LinkedIn and Instagram.

OMI-IR

OMI-CORP

Contacts

Media contact

Stacy Law
mediarelations@owens-minor.com

Owens & Minor, Inc.

NYSE:ACH
Details
Headquarters: Richmond, VA
CEO: Edward Pesicka
Employees: 6000
Organization: PUB

Release Versions

Contacts

Media contact

Stacy Law
mediarelations@owens-minor.com

Social Media Profiles
More News From Owens & Minor, Inc.

Accendra Health Announces Expiration and Final Results of Offers and Consent Solicitations

RICHMOND, Va.--(BUSINESS WIRE)--Accendra Health, Inc. (NYSE: ACH) (the “Company”) today announced the expiration and final results of the previously announced offers to exchange (the “Exchange Offers”) any and all of the Company’s outstanding 4.500% Senior Notes due 2029 (the “2029 Notes”) and 6.625% Senior Notes due 2030 (the “2030 Notes” and, together with the 2029 Notes, the “Existing Notes”). As of 5:00 P.M., New York City time, on June 23, 2026 (the “Expiration Time”), the Company received...

Accendra Health Announces Early Results of Offers and Consent Solicitations

RICHMOND, Va.--(BUSINESS WIRE)--Accendra Health, Inc. (NYSE: ACH) (the “Company”) today announced the early results of the previously announced offers to exchange (the “Exchange Offers”) any and all of the Company’s outstanding 4.500% Senior Notes due 2029 (the “2029 Notes”) and 6.625% Senior Notes due 2030 (the “2030 Notes” and, together with the 2029 Notes, the “Existing Notes”). Eligible Holders of 2029 Notes that participate in the New Money Notes Issuance (as defined below) will be able to...

Accendra Health Announces Offers and Consent Solicitations

RICHMOND, Va.--(BUSINESS WIRE)--Accendra Health, Inc. (NYSE: ACH) (the “Company”) today announced that it has commenced an offer to exchange (the “Exchange Offers”) any and all of the Company’s outstanding 4.500% Senior Notes due 2029 (the “2029 Notes”) and 6.625% Senior Notes due 2030 (the “2030 Notes” and, together with the 2029 Notes, the “Existing Notes”). Eligible Holders of 2029 Notes that participate in the New Money Notes Issuance (as defined below) will be able to exchange such 2029 No...
Back to Newsroom